Evaluation of a Standardized Protocol for Medical Management of Uncomplicated Acute Type B Aortic Dissection.

Antony Aziz,Hee Soo Jung,Paul DiMusto,Hannah O’Donnell,Donald G. Harris
DOI: https://doi.org/10.1016/j.jvs.2022.03.882
IF: 4.86
2022-05-15
Journal of Vascular Surgery
Abstract:The goals of medical management for uncomplicated acute type B aortic dissection are to prevent expansion of the false lumen and malperfusion syndrome. This is accomplished with antihypertensive agents, but medication selection and titration are typically provider dependent. Given the paucity of data on evidence-based management of this population, we hypothesized that a standardized type B aortic dissection medical management protocol would reduce resource utilization and costs, without compromising patient outcomes. A multidisciplinary team developed a goal-directed protocol to standardize the medical management of uncomplicated acute type B aortic dissection, with an emphasis on early initiation of oral medications, weaning of anti-hypertensive infusions and frequent assessment for de-escalation of care. Implementation was in April 2018. A retrospective review of acute type B aortic dissection patients presenting to our institution from April 2016- April 2020 was performed. Patients requiring aortic or peripheral intervention were excluded. Included patients were analyzed based on treatment before or after protocol implementation. Patient demographics, systolic blood pressure, presence of acute kidney injury at presentation, length of stay, cost metrics, and 30-day mortality were compared. 39 patients were included, 21 pre- and 18 post-protocol implementation. Baseline demographics, systolic blood pressure, and presence of acute kidney injury at presentation were similar between the groups. Post-protocol patients had shorter total (8.6 vs 5.5 days, p=.02) and intensive care unit (3.2 vs 1.8 days, p=.002) length of stay. The protocol was associated with significantly decreased total hospital ( 28,066, p=.04), total variable ( 15,627, p=0.02), and pharmacy ( 1,181, p
surgery,peripheral vascular disease
What problem does this paper attempt to address?